At Globallux, we are committed to transforming complex drug development into scalable, high-impact solutions that drive better health outcomes and create long-term value across the pharmaceutical value chain.
With deep expertise in regulatory strategy, complex generics, and differentiated drug delivery platforms, our portfolio is designed to meet the evolving needs of patients, caregivers, and global healthcare systems.
Enhancing Patient Compliance & Therapeutic Adherence
Our formulations are engineered to optimize convenience, reduce dosing complexity, and improve real-world treatment effectiveness — a critical driver of outcomes and long-term brand sustainability.
Complex Generics & 505(b)(2) Product Development
We leverage the 505(b)(2) regulatory pathway and advanced formulation technologies to bring differentiated products to market faster, with reduced risk and enhanced exclusivity potential.
First-to-File and NCE-1 Market StrategiesGloballux actively targets high-value opportunities through early entry and lifecycle extension, focusing on NCE-1 and first-wave generic launches that offer significant commercial upside.
Geriatric & Pediatric-Friendly Formulations
Our age-adapted drug delivery systems are designed with real-world use in mind — ensuring accessibility, tolerability, and ease of administration for the most vulnerable patient groups.
Value-Driven Oral Solid Dosage Technologies
By combining innovation with unmet clinical needs, our oral solid products achieve superior patient outcomes and support brand differentiation in crowded markets.
Caregiver-Oriented Solutions
We recognize the growing role of caregivers in treatment adherence. Our product designs simplify administration, reduce burden, and support treatment success in home and outpatient settings.
.png)